Feature

Research Reports

KRAS/RAS Testing Is Associated With Reduced Risk of Treatment Discontinuation in Patients With Metastatic Colorectal Cancer

08/22/2018

Alexandra Christodoulopoulou, MSc

Bruce A Bach, MD, PhD

Andrew J Klink, PhD, MPH

Guy Hechmati, MD, MSc

Urvi Mujumdar, MPH

Bruce A Feinberg, DO

Marwan Fakih, MD

Abstract: Current clinical guidelines recommend that all patients with metastatic colorectal cancer (mCRC) have tumor tissue genotyped for RAS mutations. This study aimed to evaluate patient characteristics and...

...

08/22/2018

Journal of Clinical Pathways

Research Reports

How Oncology Care Decision-Makers Define Clinical Pathway Programs: Conceptual vs Reported Definitions

06/14/2018

Amy Schroeder, RPh

Abstract: The American Society of Clinical Oncology (ASCO) has set forth foundational policy statements regarding the utility of clinical pathways in oncology and outlined basic requirements and aims from clinical...

...

06/14/2018

Journal of Clinical Pathways

From the Field

Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplant Program

06/08/2018

Belinda R Avalos, MD

Jonathan Gerber, MD

Saad Z Usmani, MD, FACP

Michael R Grunwald, MD

Nilanjan Ghosh, MD, PhD

Manisha Bhutani, MD, PhD

Jigar Trivedi, MS, PharmD, BCOP

Dragos Plesca, PharmD, PhD, BCOP

Tammy Cogdill, MSN, ANP-BC, OCN

Zainab Shahi

To read the full article, click here.

To...

06/08/2018

Journal of Clinical Pathways

Perspectives

The Evolution of Care for Acute Myeloid Leukemia and the Challenges of Defining Value

05/21/2018

William J Cardarelli, PharmD

Abstract: Adult acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. Distinct subtypes of AML have been defined based on morphology, immunophenotyping, and molecular genetics. AML usually progresses...

...

05/21/2018

Journal of Clinical Pathways

From the Field

A Novel Clinical Pathways Approach to Delivering Regional-Based Clinical Trials and Patient Care in a Hybrid Academic-Community-Based System

05/15/2018

Kathryn E Patronik, MHA

Edward S Kim, MD, FACP

Abstract: The health care landscape is becoming constantly more complex with new drug treatments and molecular testing. In order to achieve consistent, up-to-date patient care, clinical pathways are becoming...

...

05/15/2018

Journal of Clinical Pathways

From the Field

A Community Practice Perspective on Implementation of the Oncology Care Model

05/15/2018

Anne Marie Fraley Rainey, MSN, RN, CHC

Abstract: Clearview Cancer Institute is a private, community practice participating in the Oncology Care Model (OCM), an innovative pilot project sponsored by the Centers for Medicare and Medicaid Innovation....

...

05/15/2018

Journal of Clinical Pathways

Perspectives

Creating Value in Cancer Care Through Standardized Metrics and Partnerships Between Patient Navigators and Physicians

04/17/2018

Tricia Strusowski, MS, RN

Abstract: While providers and care systems can agree that effective patient navigation programs are essential to positive patient outcomes, there have been no standard metrics that could be used to measure the...

...

04/17/2018

Journal of Clinical Pathways

From the Field

Mock Clinical Pathways: Exploring the Process of Developing a Pathway for Metastatic Breast Cancer

02/15/2018

Bruce A Feinberg, DO

Chadi Nabhan, MD, MBA, FACP

Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care delivery, allowing for cost reduction as well as more predictable, measurable, and accountable outcomes. At the 2nd Annual...

Abstract: Clinical...

02/15/2018

Journal of Clinical Pathways

Research Reports

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting

02/15/2018

Casey Mason

Peter G Ellis, MD

Kathy Lokay

Amanda Barry, MPH

Natalie Dickson, MD

Ray Page, DO, PhD

Blase Polite, MD

Ravi Salgia, MD, PhD

Michael Savin, MD

Corey Shamah, MD

Mark A Socinski, MD

Abstract: Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non–small cell lung cancer (NSCLC), there...

...

02/15/2018

Journal of Clinical Pathways

Research Reports

Costs of Care for Patients Receiving Chemotherapy for Advanced Bladder Cancer

12/13/2017

Ashish M Kamat, MD, MBBS

Xiting Cao, PhD

Jinghua He, PhD, MPH

Yichen Zhong, MPH

Amishi Y Shah, MD

Kyle Flannery, PharmD, MS

12/13/2017

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products